Hematopoietic stem cell- and induced pluripotent stem cell-derived CAR-NK cells as reliable cell-based therapy solutions.
Saved in:
| Title: | Hematopoietic stem cell- and induced pluripotent stem cell-derived CAR-NK cells as reliable cell-based therapy solutions. |
|---|---|
| Authors: | Arias J; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.; Bright SA, Luxembourg, Luxembourg., Yu J; Bright SA, Luxembourg, Luxembourg.; Tianjin Medical University Cancer Institute and Hospital, Department of Lymphoma, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, People's Republic of China., Varshney M; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.; JoinCells Nordic AB, Karolinska Institutet Science Park AB, Huddinge, Sweden., Inzunza J; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.; JoinCells Nordic AB, Karolinska Institutet Science Park AB, Huddinge, Sweden., Nalvarte I; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.; JoinCells Nordic AB, Karolinska Institutet Science Park AB, Huddinge, Sweden. |
| Source: | Stem cells translational medicine [Stem Cells Transl Med] 2021 Jul; Vol. 10 (7), pp. 987-995. Date of Electronic Publication: 2021 Feb 26. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101578022 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-6580 (Electronic) Linking ISSN: 21576564 NLM ISO Abbreviation: Stem Cells Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
